VISTOGARD: payments to doctors
Payments that named VISTOGARD as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $62K
- Providers
- 23
- Transactions
- 37
- Average per transaction
- $1,673
The per-transaction average — $1,673 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23 providers the average total is $2,691, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| BTG International Inc. | $51,578 | 83.3% |
| BTG International, Inc. | $10,322 | 16.7% |